Synopsis
0
FDA Orange Book
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26039
Submission : 2012-05-07
Status :
Type : II
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35899
Submission : 2021-04-29
Status :
Type : II
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35878
Submission : 2021-05-11
Status :
Type : II
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24508
Submission : 2010-12-20
Status :
Type : II
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38333
Submission : 2023-05-08
Status :
Type : II
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27373
Submission : 2013-07-31
Status :
Type : II
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24507
Submission : 2010-12-20
Status :
Type : II
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38036
Submission : 2023-03-14
Status :
Type : II
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35998
Submission : 2021-06-06
Status :
Type : II
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26360
Submission : 2012-08-20
Status :
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
Sodium Hyaluronate, HA-E3.0 (intrinsic Viscosity...
Certificate Number : R1-CEP 2015-201 - Rev 00
Status : Valid
Issue Date : 2021-11-05
Type : Chemical
Substance Number : 1472
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
Sodium Hyaluronate, Intrinsic Viscosity 1.25 M3/...
Certificate Number : R0-CEP 2021-258 - Rev 02
Status : Valid
Issue Date : 2023-03-08
Type : Chemical
Substance Number : 1472
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
Sodium Hyaluronate, Intrinsic Viscosity 1.4 M3/k...
Certificate Number : R1-CEP 2016-172 - Rev 00
Status : Valid
Issue Date : 2023-05-02
Type : Chemical
Substance Number : 1472
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
Sodium Hyaluronate, Intrinsic Viscosity 3.8 M3/k...
Certificate Number : R0-CEP 2022-129 - Rev 01
Status : Valid
Issue Date : 2023-05-31
Type : Chemical
Substance Number : 1472
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
Sodium Hyaluronate, Intrinsic Viscosity 0.6 M3/k...
Certificate Number : R0-CEP 2021-446 - Rev 01
Status : Valid
Issue Date : 2023-06-15
Type : Chemical
Substance Number : 1472
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
Sodium Hyaluronate, HA-EP 1.8 (intrinsic Viscosi...
Certificate Number : CEP 2010-289 - Rev 04
Status : Valid
Issue Date : 2023-09-15
Type : Chemical
Substance Number : 1472
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
Sodium Hyaluronate, Intrinsic Viscosity 2.4 M3/k...
Certificate Number : CEP 2018-107 - Rev 04
Status : Valid
Issue Date : 2024-02-19
Type : Chemical
Substance Number : 1472
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
Sodium Hyaluronate, HA-E2.0 (intrinsic Viscosity...
Certificate Number : CEP 2015-200 - Rev 01
Status : Valid
Issue Date : 2024-03-05
Type : Chemical
Substance Number : 1472
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
Sodium Hyaluronate, Intrinsic Viscosity 2.5 M3/k...
Certificate Number : CEP 2017-195 - Rev 01
Status : Valid
Issue Date : 2024-05-02
Type : Chemical
Substance Number : 1472
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
Sodium Hyaluronate, Intrinsic Viscosity 1.8 M3/k...
Certificate Number : CEP 2021-220 - Rev 02
Status : Valid
Issue Date : 2024-06-12
Type : Chemical
Substance Number : 1472
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Minbiotech
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Topical
Solubilizers
Granulation
Co-Processed Excipients
Fillers, Diluents & Binders
Emulsifying Agents
Controlled & Modified Release
Direct Compression
Coating Systems & Additives
Taste Masking
API Stability Enhancers
Surfactant & Foaming Agents
Disintegrants & Superdisintegrants
Film Formers & Plasticizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
EDQM
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
11
PharmaCompass offers a list of Sodium Hyaluronate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Hyaluronate manufacturer or Sodium Hyaluronate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Hyaluronate manufacturer or Sodium Hyaluronate supplier.
PharmaCompass also assists you with knowing the Sodium Hyaluronate API Price utilized in the formulation of products. Sodium Hyaluronate API Price is not always fixed or binding as the Sodium Hyaluronate Price is obtained through a variety of data sources. The Sodium Hyaluronate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A SHISEIDO SODIUM HYALURONATE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of SHISEIDO SODIUM HYALURONATE, including repackagers and relabelers. The FDA regulates SHISEIDO SODIUM HYALURONATE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. SHISEIDO SODIUM HYALURONATE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of SHISEIDO SODIUM HYALURONATE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A SHISEIDO SODIUM HYALURONATE supplier is an individual or a company that provides SHISEIDO SODIUM HYALURONATE active pharmaceutical ingredient (API) or SHISEIDO SODIUM HYALURONATE finished formulations upon request. The SHISEIDO SODIUM HYALURONATE suppliers may include SHISEIDO SODIUM HYALURONATE API manufacturers, exporters, distributors and traders.
click here to find a list of SHISEIDO SODIUM HYALURONATE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A SHISEIDO SODIUM HYALURONATE DMF (Drug Master File) is a document detailing the whole manufacturing process of SHISEIDO SODIUM HYALURONATE active pharmaceutical ingredient (API) in detail. Different forms of SHISEIDO SODIUM HYALURONATE DMFs exist exist since differing nations have different regulations, such as SHISEIDO SODIUM HYALURONATE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A SHISEIDO SODIUM HYALURONATE DMF submitted to regulatory agencies in the US is known as a USDMF. SHISEIDO SODIUM HYALURONATE USDMF includes data on SHISEIDO SODIUM HYALURONATE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The SHISEIDO SODIUM HYALURONATE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of SHISEIDO SODIUM HYALURONATE suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The SHISEIDO SODIUM HYALURONATE Drug Master File in Japan (SHISEIDO SODIUM HYALURONATE JDMF) empowers SHISEIDO SODIUM HYALURONATE API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the SHISEIDO SODIUM HYALURONATE JDMF during the approval evaluation for pharmaceutical products. At the time of SHISEIDO SODIUM HYALURONATE JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of SHISEIDO SODIUM HYALURONATE suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a SHISEIDO SODIUM HYALURONATE Drug Master File in Korea (SHISEIDO SODIUM HYALURONATE KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of SHISEIDO SODIUM HYALURONATE. The MFDS reviews the SHISEIDO SODIUM HYALURONATE KDMF as part of the drug registration process and uses the information provided in the SHISEIDO SODIUM HYALURONATE KDMF to evaluate the safety and efficacy of the drug.
After submitting a SHISEIDO SODIUM HYALURONATE KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their SHISEIDO SODIUM HYALURONATE API can apply through the Korea Drug Master File (KDMF).
click here to find a list of SHISEIDO SODIUM HYALURONATE suppliers with KDMF on PharmaCompass.
A SHISEIDO SODIUM HYALURONATE CEP of the European Pharmacopoeia monograph is often referred to as a SHISEIDO SODIUM HYALURONATE Certificate of Suitability (COS). The purpose of a SHISEIDO SODIUM HYALURONATE CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of SHISEIDO SODIUM HYALURONATE EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of SHISEIDO SODIUM HYALURONATE to their clients by showing that a SHISEIDO SODIUM HYALURONATE CEP has been issued for it. The manufacturer submits a SHISEIDO SODIUM HYALURONATE CEP (COS) as part of the market authorization procedure, and it takes on the role of a SHISEIDO SODIUM HYALURONATE CEP holder for the record. Additionally, the data presented in the SHISEIDO SODIUM HYALURONATE CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the SHISEIDO SODIUM HYALURONATE DMF.
A SHISEIDO SODIUM HYALURONATE CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. SHISEIDO SODIUM HYALURONATE CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of SHISEIDO SODIUM HYALURONATE suppliers with CEP (COS) on PharmaCompass.
A SHISEIDO SODIUM HYALURONATE written confirmation (SHISEIDO SODIUM HYALURONATE WC) is an official document issued by a regulatory agency to a SHISEIDO SODIUM HYALURONATE manufacturer, verifying that the manufacturing facility of a SHISEIDO SODIUM HYALURONATE active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting SHISEIDO SODIUM HYALURONATE APIs or SHISEIDO SODIUM HYALURONATE finished pharmaceutical products to another nation, regulatory agencies frequently require a SHISEIDO SODIUM HYALURONATE WC (written confirmation) as part of the regulatory process.
click here to find a list of SHISEIDO SODIUM HYALURONATE suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing SHISEIDO SODIUM HYALURONATE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for SHISEIDO SODIUM HYALURONATE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture SHISEIDO SODIUM HYALURONATE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain SHISEIDO SODIUM HYALURONATE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a SHISEIDO SODIUM HYALURONATE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of SHISEIDO SODIUM HYALURONATE suppliers with NDC on PharmaCompass.
SHISEIDO SODIUM HYALURONATE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of SHISEIDO SODIUM HYALURONATE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right SHISEIDO SODIUM HYALURONATE GMP manufacturer or SHISEIDO SODIUM HYALURONATE GMP API supplier for your needs.
A SHISEIDO SODIUM HYALURONATE CoA (Certificate of Analysis) is a formal document that attests to SHISEIDO SODIUM HYALURONATE's compliance with SHISEIDO SODIUM HYALURONATE specifications and serves as a tool for batch-level quality control.
SHISEIDO SODIUM HYALURONATE CoA mostly includes findings from lab analyses of a specific batch. For each SHISEIDO SODIUM HYALURONATE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
SHISEIDO SODIUM HYALURONATE may be tested according to a variety of international standards, such as European Pharmacopoeia (SHISEIDO SODIUM HYALURONATE EP), SHISEIDO SODIUM HYALURONATE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (SHISEIDO SODIUM HYALURONATE USP).
